Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Medtronic
Colorcon
Baxter
Express Scripts

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,559,305

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,559,305 protect, and when does it expire?

Patent 6,559,305 protects ZYVOX and is included in three NDAs.

Protection for ZYVOX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-one patent family members in thirty countries.

Summary for Patent: 6,559,305
Title: Linezolid--crystal form II
Abstract:The invention is a novel crystal form (Form II) of a known compound, linezolid ##STR1## which is useful as an antibacterial agent.
Inventor(s): Bergren; Michael S. (Portage, MI)
Assignee: Pharmacia & Upjohn Company (Kalamazoo, MI)
Application Number:10/154,359
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,559,305
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 6,559,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pharmacia And Upjohn ZYVOX linezolid FOR SUSPENSION;ORAL 021132-001 Apr 18, 2000 AB RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Pharmacia And Upjohn ZYVOX linezolid SOLUTION;INTRAVENOUS 021131-001 Apr 18, 2000 AP RX Yes No   Start Trial   Start Trial Y   Start Trial
Pharmacia And Upjohn ZYVOX linezolid SOLUTION;INTRAVENOUS 021131-002 Apr 18, 2000 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Pharmacia And Upjohn ZYVOX linezolid SOLUTION;INTRAVENOUS 021131-003 Apr 18, 2000 AP RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Pharmacia And Upjohn ZYVOX linezolid TABLET;ORAL 021130-001 Apr 18, 2000 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Colorcon
Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.